Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery

Completed · Phase 1/Phase 2

Conditions studied: Cardiovascular Diseases, Heart Diseases, Heart Defects, Congenital

In brief

This study will determine the pharmacokinetics and safety of intravenous citrulline given to children undergoing cardiopulmonary bypass for the correction of congenital heart defects.

Key facts

Study ID

NCT00201214

Run by

Vanderbilt University

People needed

26

Starts

2003-12-01

Expected to finish

2009-12-01

Last updated by the study team

2013-09-12

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing cardiopulmonary bypass via one of the following surgical procedures:
• AVSD repair
• VSD repair
• Bidirectional Glenn
• Modified Fontan
• Arterial Switch
• Parents willing and able to sign consent

You may not qualify if…

• Pulmonary artery or vein abnormalities not being addressed surgically
• Preoperative requirement for mechanical ventilation or intravenous inotrope support
• Any condition that might interfere with study objectives

Where it is running

• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.